Introduction

Neuroscience Congress 2025 invites all the participants from all over the world to attend 30th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences during July 07, 08, 2025 in Vancouver, Canada  which includes prompt keynote presentations, oral talks, poster presentations, workshops and exhibitions.

Why to attend?

With members from around the world focused on learning about neuropharmacology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Neurology & Neuroscience community conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Neurochemistry & Neuropharmacology are hallmarks of this conference.

Target Audience:

• Neurologists
• Neuro Surgeons
• Neuroscience professors 
• Neurochemistry Students
• Neurochemistry Scientists
• Neurochemistry Researchers
• Neurochemistry  Faculty
• Medical Colleges
• Neurochemistry Associations and Societies
• Manufacturing Medical Devices Companies
• Neuropharmacology Students
• Neuropharmacology Scientists
• Neuropharmacology Researchers
• Neuropharmacology Faculty
• Neuropharmacology Associations and Societies
• Business Entrepreneurs
• Training Institutes

2025 Highlights:

• 300+ Participation (70 Industry: 30 Academia)
• 5+ Keynote Speakers
• 50+ Plenary Speakers
• 14 Innovative Educational Sessions
• 5+ Workshops
• B2B Meetings

Advantages of Participating at our Conference

• The advantages of the Speaker and abstract pages are created in Google on your profile under your name would get worldwide visibility.
• Our comprehensive online advertising attracts 30000+ users and 50000+ views to our Library of Abstracts, which takes researchers and speakers to our conference.
• Meet with hundreds of like-minded experts who are pioneers in Neurology and share ideas.
• All participants in the conference would have a different reason to participate with eminent speakers and renowned keynote speakers in one-to-one meetings.
• A rare opportunity to listen what the world's experts are learning about from the world's most influential researchers in the area of neuroscience at our Keynote sessions.
• Neuro Summit intensive conference schedule, you will acquire experience and expertise in strategic gift preparation that is worth its weight golf, forming an impressive array of recognised professionals.
• Best Poster Award nominations.
• Award for Outstanding Young Researcher.
• Group Registration Advantages.

Benefits of Participation for Speaker

• Worldwide appreciation of the profile of Researchers.
• Obtain credits for professional growth.
• Explore the latest of cutting edge analysis.
• Make long-term bonds at social and networking activities.
• An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
• Learn a transition beyond your area of interest to learn more about new subjects and studies away from your  core subject of Neurology.
• We have distinctive networking, learning and enjoyable integration into a single package.

Benefits of Participation for Delegate

• Professional Development-Improve understanding and knowledge.
• Attendance at  conference supports, rejuvenates and energises delegates.
• Your involvement in our conference will help with a new methodology and ideology that can be used to broaden the outcomes of businesses or industries.
• Opportunities for Neuro Summit researchers and experts in the same field to meet and exchange new ideas through an conference.

Benefit of Participation for Sponsor

• Exposure to the international environment would increase the possibility of new companies.
• Opportunity to demonstrate your company's latest technologies, new products, or service your business to a wide range of  international participants.
• Increase business by our conference participants through lead generation.
• It takes a lot of time, effort and drive to create a successful company, so it's always nice to have a network of colleagues and associates to draw energy from individuals who share a common drive and  objective.
• Conferences in neurology provide opportunities for more attention and contemplation that could help you move your company to the next stage.
• Benchmarking main organization plans and moving it forward.
• Get feedback from trustworthy people at our conference to your company questions and challenges.
• On our conference banner, website and other proceedings, branding and marketing content, the advertising logo of your company.

Benefit of Association for Collaborators

• Nobody has this massive visitors to Neurology in the world, this is the best forum to highlight society.
• Creating long-lasting peer relationships.
• In our conference banner, website and other proceedings, branding and marketing material, promotional content and your Organization logo will increase your number of subscribers/members by 40%.
• The exposure of our event to your Company listing in the Global Business forum will have a great effect on your association.
• Your representatives can network to update their knowledge and understanding of your organisation and services with key conference delegates.
• Neurology advertising materials such as posters, brochures, pamphlets, services that will be circulated to hospitals, universities, society and researchers will be integrated with information.

Sessions/Tracks

Highlights of latest advances on 30th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences. It provides a platform to have open discussions, knowledge sharing and interactive sessions with field experts at Neurochemistry, Neuropharmacology and Neurosciences 2025. We request you to submit a brief idea or abstract of your talk/presentation/symposium/workshop according to your session interest.

Track 1: Neurology and Neuroscience

• Neuroinflammation in neurodegenerative diseases
• Brain Patterning & Brain Mapping
• Neurophysiology
• Central nervous system
• Peripheral nervous system
• General neurology

Track 2: Neurochemistry and Neuropharmacology

• Chemical Neurobiology
• Molecular Mechanisms & Regulation of Nervous System
• Molecular and Cellular neurochemistry
• Therapeutics and Clinical Neuropharmacology
• Therapeutics for specific syndromes and symptoms in Clinical Neuropharmacology
• Hypothalamic releasing factors of Clinical Neuropharmacology

Track 3: Brain Tumors and Neurosurgery 

• Acoustic neuroma
• Brain metastases
• Craniopharyngioma
• Embryonal tumors
• Ependymoma
• Glioblastoma
• Pineoblastoma
• Pituitary tumors
• Vascular neurosurgery
• Stereotactic neurosurgery/ functional neurosurgery
• Oncological neurosurgery
• Spinal neurosurgery

Track 4: Alzheimers and Parkinsons disease

• Early-onset Alzheimers
• Late-onset Alzheimers
• Secondary Parkinsonism
• Parkinsonian gait
• Parkinsonism
• Brain cell death
• Bradykinesia
• Parkinsons care, rehabilitation, and treatments

Track 5: Dementia and Vascular Dementia

Dementia is usually caused by degeneration in the cerebral cortex, the part of the brain responsible for thoughts, memories, actions, and personality. Death of brain cells in this region leads to the cognitive impairments that characterise dementia. Causes of dementia include head injury, brain tumours, infections, hormone disorders, metabolic disorders, hypoxia, nutritional deficiencies, drug abuse, or chronic alcoholism. Unfortunately, most disorders associated with dementia are progressive, degenerative and irreversible. The two major degenerative causes of dementia are Alzheimer's disease and vascular dementia Multiple neuropathologic processes may underlie dementia, including both neurodegenerative diseases and vascular disease. Dementia is most common in elderly individuals, with advancing age being the strongest risk factor.

Vascular Dementia is the broad term for dementia associated with problems of circulation of blood to the brain. Vascular brain injury (VBI) is widely recognized as a common cause of cognitive impairment (vascular cognitive impairment) culminating in vascular dementia. Most vascular dementia cases are sporadic and share risk factors with peripheral vascular disease. Vascular dementia is not a single disease; it is a group of syndromes relating to different vascular mechanisms.

• Symptoms of Dementia
• Mixed dementia
• Stroke & Dementia
• Causes of Dementia
• Treatments for Dementia
• Cerebrovascular disease
• Erythrocyte sedimentation rate
• Hypercholesterolemia

Track 6: Cognitive Neuroscience and Behavioral neuroscience

Cognitive neuroscience is the scientific field that is concerned with the study of the biological processes and aspects that underlie cognition, with a specific focus on the neural connections in the brain which are involved in mental processes.  It addresses the questions of how cognitive activities are affected or controlled by neural circuits in the brain. Cognitive neuroscience is a branch of both neuroscience and psychology, overlapping with disciplines such as physiological psychology, cognitive psychology, and neuropsychology. Cognitive neuroscience relies upon theories in cognitive science coupled with evidence from Neuropsychology, and Computational modelling.

Concepts of motivation are vital to progress in behavioural neuroscience. Motivational concepts help us to understand what limbic brain systems are chiefly evolved to do, i.e., to mediate psychological processes that guide real behavior.

• Causes of Dementia
• Cognitive Psychology
• Neuropsychology
• Experimental Psychology
• Physiological psychology
• Cognitive genomics
• Complications of mental illness
• Translational Research
• Internal medicine
• Aggressiveness
• Allostasis developmental psychology

Track 7: Epilepsy

Epilepsy a chronic condition is a disorder of the central nervous system in which regular seizures occur. Brain activity is irregular in epilepsy, leading to repeated seizures, erratic behaviour, loss of consciousness and sensations. Regardless of gender, race, and age, epilepsy can happen to anyone.

Seizures are a significant symptom of epilepsy. Two types of seizures are primarily present: focal seizures and generalised seizures. The other signs include a person's sudden fall without any reason. Epilepsy is caused by genetic or environmental causes. The causes of acquired epilepsy include stroke, cancers, brain damage and brain infection. The genetic cause of epilepsy is more common in young people, and brain tumours and strokes are more prevalent in older people. The precise cause of most cases of epilepsy is unclear. An electroencephalogram, computed tomography (CT) scan, magnetic resonance imaging (MRI), and neuroimaging can be used to observe epilepsy. To recognise the disorders in the brain during a seizure and to look at the minute changes in the structure of the brain, these techniques may provide a clearer view.

• Seizure
• Epilepsy surgery
• Epileptogenic
• Photosensitive epilepsy
• Generalized seizures
• Focal seizures
• Epilepsy treatment

Track 8: Stroke and Neurological Disorders

A stroke is a restorative crisis. stroke happens when bloodstream to your mind stops. Inside minutes, cerebrum cells start to die. There are two sorts of stroke. The more normal kind, called ischemic stroke, is created by a blood coagulation that squares or attachments a vein in the cerebrum. The other kind, called haemorrhagic stroke, is brought on by a vein that breaks and seeps into the cerebrum. "Smaller than normal strokes" or transient ischemic assaults (TIAs), happen when the blood supply to the cerebrum has quickly interfered. Stroke is the third driving reason for death in the United States. Of the more than 700,000 individuals influenced each year, around 500,000 of these are first assaults, and 200,000 are intermittent. Around 25 percent of individuals who recuperate from their first stroke will have another stroke inside five years. Stroke is the main source of genuine long-haul handicap.

• Cardiac Complications of Neuromuscular Disorder
• Lambert-Eaton syndrome
• Myasthenia
• Brain Disorders
• Neurodegenerative diseases
• Traumatic brain injuries
• Narcolepsy

Track 9: Computational Neurology and Neuroinformatics 

Computational neuroscience is distinct from psychological connectionism and machine learning in that it emphasizes descriptions of functional and biologically realistic neurons (and neural systems) and their physiology and dynamics. These models capture the essential features of the biological system at multiple spatial-temporal scales, from membrane currents, protein and chemical coupling to network oscillations, columnar and topographic architecture and learning and memory. These computational models are used to frame hypotheses that can be directly tested by current or future biological and/or psychological experiments.

Neuroinformatic is an examination field worried with the association of neuroscience information using computational models and explanatory apparatuses. These territories of research are critical for the coordination and investigation of progressively extensive volume, high-dimensional, and fine-grain exploratory information. Neuroinformaticians give computational instruments, scientific models, and make interoperable databases for clinicians and research researchers.

• Single neuron modelling
• Development, axonal patterning, and guidance
• Sensory processing
• Memory and synaptic plasticity
• Behaviours of networks Neural Computation
• Neuroengineering
• Brain Informatics
• Analysis and modelling of CNS and neuronal system

Track 10: Neuro Immunology and Neurological Infections

Neuroimmunology refers to the interdisciplinary field merging neurology, immunology, and aspects of neuroscience. It is a scientific and clinical domain. Scientifically, neuroimmunology tries to understand the bidirectional links between the nervous and immune systems, and their implications to illnesses. Multiple Sclerosis and Related Disorders is a priceless expansion to the writing and will be of critical enthusiasm to neurologists, inhabitants and colleagues, internists, and general professionals who treat patients having a neurologic issue and other systemic immune system illnesses. The resistant framework direct protection against these creatures, wastefulness of similar outcomes in Infections. The condition is much more regrettable in creating nations; it has been a noteworthy medical issue in Australia. Somewhere in the range of 350,000 to 500,000 patients experience the ill effects of different sclerosis (MS) in the United States.

• Multiple sclerosis
• Biopsy
• Neuroimmune genetics
• Neurovirology
• Neuroinflammation
• Neuroinfectious disease
• Neuromodulation Alteration
• Novel Drug development

Track 11: Neuro Cardiology

Neurocardiology is the study of neurophysiological, neurological and neuroanatomical aspects of cardiology especially including the neurological origins of cardiac disorders. It also refers to the pathophysiological interplays of the nervous and cardiovascular systems. The effects of stress on the heart are studied in terms of the heart's interactions with the two peripheral nervous system and central nervous system. Scientific issues in neurocardiology include hypoxic-ischemic brain injury, neurogenic stress cardiomyopathy, cerebral embolism and encephalopathy, neurologic sequelae of cardiac and thoracic surgery, cardiac interventions, and cardiovascular findings in patients with primary neurological disease.

Track 12: Neuro-Oncology

The nervous system is getting affected by cancer is one of the severe conditions. The study of cancers of the nervous system is known as Neuro Oncology. It is a branch of medicine which deals with brain and spinal cord neoplasms. In the end, in most situations, it becomes deadly. For malignant and benign spinal cord and brain tumours, it performs research, investigation, identification, and care.

Neuro-Oncology deals with multiple tumours, such as Central Nervous System (CNS) primary tumours and CNS metastatic tumours, and their numerous first-place causative factors. Pons' gliomas, brain stem gliomas, glioblastoma multiforme, and astrocytoma are some of the worst types of cancer.

• Drug use by Adolescents
• Alcoholism & Addiction
• CNS & Addictive Disorders
• Behavioural Addication
• Addication Theraphy
• Radiation Oncology
• Paediatric Oncology
• Emerging Concepts in Neuro-Oncology

Track 13: Pediatric Neurology

Pediatric neurology happens mostly in youngsters or teenagers. Neurology influences around 6 in 100,000 youngsters. Neurology in kids is of three essential sorts in whom two are ischemic neurology in which blockage of veins outcome in absence of blood stream and harm. At the point when a corridor is blocked, the term blood vessel ischemic neurology (AIS) is utilized. At the point when a vein is block, the term utilized is cerebral Sino venous thrombosis (CSVT). In the third shape, haemorrhagic neurology (HS), the vein crack as opposed to being blocked. The most known signs and side effects of neurology incorporate the sudden appearance of failing or deadness of the face, arm or leg, more often than not on one side of the body.

• Sleep disorders
• Behavioral disorders
• Cerebral palsy
• Childhood epilepsy
• Concussion and Migraine
• Neonatal neurology
• Degenerative disorders
• Movement disorders (Cerebral paresis)
• Muscle diseases
• Lysosomal storage disease
• Brain malformations
• Development disorders

Track 14: Spine and Spinal disorders

The brain and spinal medulla form the central nervous system together. In humans, wherever it moves through the hiatus, the neural structure begins at the membrane bone, and at the beginning of the cervical vertebrae meets and joins the spinal canal. The spinal cord stretches to the body section area of the vertebral column from the medulla inside the brainstem. It encloses the neural structure's central canal that contains humour.

Spine conditions arise in persons regardless of their age-spina bifida in children and spinal stenosis in the elderly. A variety of square measurements of spinal disorders have been seen. In diagnostic methods, the increase in spinal disorders has been met with a leap in development. A variety of commonly used instruments in diagnostic spinal disorders are measured by scrutiny spine, X-rays, MRI, CT and law enforcement department square.

Track 15: Neuro Opthamology

The pediatric neurogenetic issue are sicknesses of the brain, spinal string, nerves and muscles that are caused by changes in genes or chromosomes. There are many neurogenetic issues that may display in altogether different ways. They may cause issues from birth or just wind up plainly clear in later adolescence. They incorporate mutations in the brain, neurodevelopmental disorder, hereditary disorders and issues, for example, seizures, loss of muscle tone, adjust and learn. Neurology Conferences is a distinctive platform to bring together global distinguished academics in the field of Neuroscience, Neurosurgery.

• Causes of neuro-ophthalmology
• Treatment of neuro-ophthalmology
• Neuro-ophthalmologist

Track 16: Neurophysiology, Neuroimaging and Radiology

Neurophysiology is characterized as the study of nervous system physiology and function. The functional properties of nerves, glia and neural networks are to be investigated. A part of neuroscience and physiology is neurophysiology. In neurophysiology, electrophysiological or molecular biological techniques are also used. Neurophysiology is characterized by some other researchers as a study of brain cells. It is concerned with neuroscience in mathematics, neurochemistry, electrophysiology, neuroanatomy, neuroscience in hospitals, and biophysics. Neurophysiology uses neurophysiological testing using biochemical techniques.

Neuroimaging is the visual performance of the device and brain. Intracranial unwellness is possible by neuroimaging designation of current standing and development of neurodegenerative medicine. Neuroimaging involves numerous PET, MRI, and CT appreciation strategies for designation. Biomarker would be a material inserted into species as a predictor of detective work, screening, diagnosis, efficiency of the observational organ. Biomarker shows whether or not there is a stable state or unwellness. Neuroradiologists are those who specialize in the techniques of neuroimaging. In medicine, neuroscience, and psychology, neuroimaging or brain imaging is a modern discipline for researching improvements in different neurological and psychological conditions.

• Systemic Neurophysiology
• Surgical Neurophysiology
• Neurochemistry
• Neurophysiology Facilitation of Respiration
• Clinical neurophysiology
• Metabolic Disorders in Neurophysiology
• Neuroimaging techniques and their relation with Neurology
• Recent advancements in Neuroimaging
• Functional Magnetic Resonance Imaging (fMRI)
• Magnetoencephalography
• Cranial ultrasound

Track 17: Robotic Neurosurgery 

Robotic or Robot-Assisted Surgery integrates advanced computer technology with the experience of the skilled surgeons. This technology provides the surgeon with a 10x magnified, high-definition, 3D-image of the body's intricate anatomy. The surgeon uses controls in the console to manipulate special surgical instruments that are smaller, as well as more flexible and manoeuvrable than the human hand. The robot replicates the surgeon's hand movements, while minimizing hand tremors. The surgeon thus can operate with enhanced precision, dexterity and control even during the most complex procedures. Robotic surgery is the recent new advanced technique in the field of Neurosurgery.

• The telesurgical robot (master–slave)
• Handheld shared/ controlled systems
• Intraoperative MRI for Brain Tumors

Track 18: Neuroplasticity and Neurorehabilitation

Neuroplasticity is also known as brain plasticity and neural plasticity that encompasses the two synaptic and non-synaptic plasticity and it refers to advance in neural pathways and synapses due to difference in behavior, environment, neural processes, thinking, and emotions as well as to changes resulting from bodily. The goal of this session is to understand the brain plasticity advances in neurite remodeling and how to increase neural connections. Neurorehabilitation is a medical process which aims to aid recovery from nervous system damage and to minimize or compensate for any functional alterations resulting from it.

Track 19: Neurological and Neurological Nursing

Neurological Nursing is a very challenging nursing specialty dealing with assessment, nursing diagnosis, and management of many neurological disorders for which nurses provide patient care. They are expected to work at health care clinics, hospitals and Intensive rehabilitation and brain injury units assisting complex Neuro surgeries, or with procedures in Neurointerventional Radiology and even in Clinic research areas. This includes trauma, brain injuries, stroke, seizures, tumours, headaches, infections, and aneurysms, as well as a host of other neurological complexities.

• Neurosurgery
• Neurotrauma
• Neuroscience critical/intensive care
• Long-term neurological conditions

Track 20: Clinical Interventions & Case Reports

Recent clinical studies have shown that between half-hour and hour of drug abusers have mental state diagnoses Depression, schizophrenic psychosis, and manic disorders. Drug addiction may be a typical of disorder involves the interaction of environmental factors and genetic factors to extend the susceptibility of an individual to addictive behaviour. SAMHA scientist’s area unit working on the pharmacological and neuropsychosocial models and approaches that involve pre-symptomatic studies and clinical findings, to elucidate the results of mental health and physical disorders and outcomes in drug-addicts, Researchers specialize in pregnant women smokes cigarettes. Tobacco usage elevates therapeutic and behavioral therapies in smokers with synchronous psychiatrically disorders.

• Age‐associated memory impairment
• Case reports on neurosurgery
• Health care reports
• On-going Clinical trials in neurology
• Pharmacology Resident Case Studies

Market Analysis

The societal burden of brain disorders

Brain disorders are a significant global health problem and the second largest source of deaths worldwide. Neurological and neuropsychiatric disorders are responsible for 9 million and 8 million annual deaths, respectively. This is over 30 percent of deaths which means every third person on this planet is likely to lose a family member to brain disorder.

Globally, this imposes a high cost on societies. The Global Burden of Disease Study calculates disability-adjusted life-years (DALYs) by summing years lost and years lived with disability for the global population with brain disorders. The annual DALY count is 276 million years for neurological disorders and 184 million years for neuropsychiatric conditions, adding up to 460 million years. Collectively, this represents the leading cause of disability worldwide.

These DALY and fatality metrics indicate that current treatments for brain disorders leave much room for improvement. They also highlight the desperate need for more resources to be devoted to brain disorders to elevate the standards of care.

The GNM is a half-a-trillion-dollar market dominated by behavioral therapy services

The GNM had a value of $612 billion in 2022, with an outstanding 73 percent derived from non-drug therapies. Such predominance comes as no surprise if we consider how prevalent mental health problems are in modern societies, with 264 million people suffering from depression, 284 million from anxiety and 178 million from alcohol or drug abuse disorders.

These patients need psychotherapy services involving a wide range of medical professionals, including doctors, emergency physicians, nurses, psychiatrists, psychologists and social workers. These conditions are typically chronic and require protracted interventions with recurrent service delivery, which explains the pronounced weight of behavioral therapy services in the GNM

To create this report, we segmented the global neuroscience market (GNM) to account for traditional and novel solutions to tackle brain disorders across three areas:

• diagnostic solutions (to accommodate the value of technologies facilitating the early diagnosis of brain disorders)
• drug therapies (to include conventional pharmacological methods and refined therapies targeting newly discovered molecular targets)
• and non-drug therapies (to account for the importance of behavioral interventions in treating brain disorders).

• Diagnostic solutions were subdivided into two segments. Molecular diagnostics are precision tests designed to detect biological markers at the genomic, transcriptomic, or proteomic level to accurately diagnose brain disorders. Non-molecular diagnostics are techniques to detect the presence of brain alterations based on electrophysiological (for example, EEG) or structural data (CT, MRI).
• Drug therapies were subdivided according to the nature of the disease they are intended to treat into neurological conditions and neuropsychiatric conditions (including mental health disorders).
• Non-drug therapies were subdivided into behavioral therapy services and digital health. Therapy services are a range of psychotherapies delivered across the entire continuum of care—from hospital settings to home—to address mental health issues. Digital health is software-based technologies and platforms designed for the prevention, monitoring, management or treatment of brain disorders.

With these subdivisions as the basis for our analysis, we conducted market research to estimate the revenue-based valuation of each GNM segment. We also analyzed consistent market metrics to define which segments and regions will drive GNM growth until 2026.

The findings

The GNM is a half-a-trillion-dollar market dominated by behavioral therapy services

The GNM had a value of $612 billion in 2022, with an outstanding 73 percent derived from non-drug therapies. Such predominance comes as no surprise if we consider how prevalent mental health problems are in modern societies, with 264 million people suffering from depression, 284 million from anxiety and 178 million from alcohol or drug abuse disorders.

These patients need psychotherapy services involving a wide range of medical professionals, including doctors, emergency physicians, nurses, psychiatrists, psychologists and social workers. These conditions are typically chronic and require protracted interventions with recurrent service delivery, which explains the pronounced weight of behavioral therapy services in the GNM.

The GNM is forecast to grow at a relatively low rate in the coming years, featuring a compound annual growth rate (CAGR) of 4.2 percent until 2026 with a valuation of $721 billion. However, CAGR estimates are biased towards high-value segments to the extent that more significant segments influence the metric more than smaller counterparts. So, the observed 4.2 percent CAGR could hide significant differences across segments.

Indeed, calculated growth estimates range from the high-growth digital health segment (CAGR 27.8 percent) to the low-growth behavioral therapy services segment (CAGR 3.5 percent).

Over 75% of the GNM value stems from North America and Europe

Figure 4 shows the calculated distribution of GNM share across regions. Over 50 percent of the revenue arises from North America, while approximately a quarter stems from the European market. The remaining share is accounted for by Asia-Pacific and, to a lesser extent, the Rest of the World (RoW).

This regional split is consistent across all analyzed segments, with North America ranging from 40.4 to 60.5 percent and always the major region. Europe ranges between 21.9 and 29.5 percent and is systematically the second leading region. Asia-Pacific varies between 12.1 and 21.3 percent.

It should be noted that this analysis reflects market size at current patient access levels. If patients in low-to-middle-income regions, particularly in emerging markets such as Africa, begin accessing therapy in increasing numbers, the market has much potential to grow.

The neuroscience diagnostic market is primarily driven by medical imaging and next-generation sequencing technologies

Effective implementation of early diagnosis is paramount for the optimal intervention and management of brain disorders. A wide array of technologies enables the detection of disease-specific signatures based on molecular and non-molecular data, the latter including electrophysiological and structural data.

A total of $7.9 billion in revenue was generated in 2022 for the diagnosis of brain disorders, with 83 percent stemming from non-molecular diagnostic solutions, including electrophysiology and imaging techniques such as electroencephalogram (EEG) or MRI. The remaining 17 percent resulted from molecular counterparts (for example, PCR and immunoassay).

The growth of the molecular segment is expected to be 2.5 larger than the non-molecular, with CAGR values of 17 and 7 percent, respectively. The neuroscience diagnostic market is forecast to grow with a CAGR of 8.9 percent, reaching a valuation of $11.1 billion in 2026.

The forecast change for the 2020-2025 period is equally impressive, with a projected annual retraction rate of 19.7 percent for sequencing costs and an estimated CAGR of 117.2 percent for production volume. These metrics are expected to drive revenue growth from sequencing kits and consumables in brain disorders. The projected CAGR is 17.9 percent until 2026.

Pharmacological interventions dominate the neuroscience drug market against multiple sclerosis, anxiety, mood disorders and substance abuse disorders

We analyzed the market size of pharmacological interventions for 16 brain disorders, which we sub classified as either neurological or neuropsychiatric conditions. The former accounted for $60 billion in 2022 (38 percent of the total), while the latter generated $99 billion during the same year (62 percent of the total). The projected growth for neurological and neuropsychiatric disorders is relatively similar (4.8 percent versus 5.2 percent, respectively), returning a compound CAGR of 5.1 percent.

According to this analysis, we can differentiate three clusters of segments:

• Digital health and molecular diagnostics: These segments display low value at present—below $4 billion—but are expected to grow with a fast CAGR of 27.8 and 17 percent until 2026 to reach $9.6 billion and $2.6 billion, respectively.
• Behavioral therapy services: This segment exhibits the largest revenue share—$441.1 billion—while projecting the lowest growth rate with a CAGR of 3.5 percent.
• Drugs and non-molecular diagnostics: These segments currently generate intermediate revenue levels between $7-99 billion, while exhibiting modest growth projections between 4.8 to 7 percentage points.

High-growth and high-value clusters will likely face challenges of different natures. Challenges faced by digital health and molecular diagnostics, both emerging technologies with high R&D activity, will revolve around optimization of R&D processes, effective management of clinical trials, technical validation processes and definition of value proposition and go-to-market strategies.

On the other hand, the challenges of behavioral therapies (long-standing services with little innovation) will instead focus on operational initiatives to avoid entering diseconomies of scale. The conservation of competitive advantages by increasing either the differentiation or the cost-effectiveness of their offering will also be critical.

Different GNM segments will drive future growth depending on the regions

Lastly, we analyzed the forecast CAGR for each sub segment and compared these data against the change in the regional market share each sub segment is expected to undergo between 2022 and 2026. Interestingly, this approach revealed that Europe and the Asia-Pacific are forecast to increase their market share in high growth sub segments (such as digital health for neuropsychiatry and neurology, and kits and consumables for molecular diagnostics). In contrast, in North America, the projected CAGR of a given sub segment does not seem to provide any information about the expected change in regional market share, as highlighted by the absence of correlation between these two parameters.

These results align with our earlier observation that over half of the GNM revenue is generated in North America. Accordingly, regions such as Europe and the Asia-Pacific, where the market could be more consolidated from a commercial perspective, might be more willing to fill the revenue gap by preferentially investing in the latest technological advancements (digital health, molecular diagnostics). This is not to say North America will not invest in digital health and the latest diagnostic tools. However, local investors will also aim to preserve the revenue base from long-standing, high-revenue segments such as behavioral therapy services.

Past conference report

The 29th Intenational Neurology: Neurochemistry, Neuropharmacology and Neurosciences, hosted by the Conference Series was held during March 25-26, 2024 at Toronto, Canada.  Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Neuropharmacology, who made this event a grand success.

we expresses our gratitude to the conference Moderators, namely Dr. Jong Eun Lee, Dr. Mariya Hristova and Dr. Maha Nada for taking up the responsibility to co-ordinate during the sessions. We are indebted to your support.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

• Jinwei Zhang, University of Exeter, UK
• Joey Gaines , United States of America
• Wagih G. Elbarrany, Umm Al-Qura University , Saudi Arabia
• Raafat abdeldayem, Mansoura University, Egypt
• Joao Alexandre Lobo Marques, University of Saint Joseph, China

We are greatful to our Speakers of special session. The list comprises:

• Heba Ali, Cardiff University, UK
• Aline Kegler, Federal University of Santa Maria, Brazil
• Zouhra Doukkali, ISPiTS, Rabat,Morocco
• Mona H. Haron, University of Mississippi, Unitied States
• Linchi Rani, Jawaharlal Nehru University, India
• Mir Hilal Ahmad, Jawaharlal Nehru University, India
• Danyal Daneshdoust,University of Medical Sciences Babol, Iran
• Haifen Liao, Sun Yat-sen University, China
• Raffaele Pilla, St. John of God Hospital – Fatebenefratelli, Italy

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

• Neuro Immune Pharmacology
• Molecular Neuropharmacology
• Psychopharmacology
• Neurochemical Transmission
• Behavioral Neuropharmacology
• Neurotechnology
• Neuroendocrinology
• Alzheimer’s Disease and Dementia
• Parkinson’s Disease
• Neuroethics
• Future Aspects of Neuropharmacology
• Clinical Neuropharmacology
• Chemical Neurotransmitters
• Case Study Reports
• Entrepreneurs Investment Meet

We offer our   heartfelt appreciation to organizations such as Bentham Science and our esteemed supporters SelectScience Trade Show Alerts  Medgenera CrowdReviews PBR Clinical Biometrics Bio-Equip Nanobay Pharma Focus Asia ManuscriptEdit Times International eindiabusiness  and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. We also took the privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Exhibitors who supported this event.

With the grand success of Neurosciene Congress 2024, We are proud to announce the "30th International Conference on Neurochemistry and Neuropharmacology and Neuroscienes" to be held during July 07-08, 2025 in Vancouver, Canada.

TOP UNIVERSITIES IN USA       

• Stanford University
• Massachusetts Institute of Technology
• University of California Berkeley
• University of Washington
• University of Michigan
• Cornell University
• Columbia University New York
• University of Pennsylvania
• University of California Los Angeles UCLA
• Yale University
• University of California San Diego
• Duke University
• University of Wisconsin Madison
• Johns Hopkins University
• University of Texas Austin
• Pennsylvania State University
• Princeton University
• University of North Carolina Chapel Hill
• University of Chicago
• New York University
• University of Illinois Urbana Champaign
• University of Southern California
• Northwestern University
• University of California Davis
• University of Florida
• Michigan State University
• University of Maryland College Park
• University of California Irvine
• Ohio State University
• Purdue University
• Carnegie Mellon University
• California Institute of Technology Caltech
• Washington University Saint Louis
• University of Pittsburgh
• Boston University
• University of California San Francisco
• Georgia Institute of Technology
• University of Colorado Boulder
• University of Arizona
• Rutgers The State University of New Jersey
• Arizona State University
• University of Virginia
• Texas A&M University
• Vanderbilt University
• University of California Santa Barbara
• Indiana University Bloomington
• Emory University
• Brown University
• University of Iowa
• North Carolina State University
• Virginia Polytechnic Institute and State University
• Tufts University
• University of Rochester
• University of Massachusetts Amherst
• Iowa State University
• Rice University
• University of Georgia
• University of Illinois Chicago
• University of Delaware
• City University of New York
• University at Buffalo
• University of Tennessee Knoxville
• Florida State University
• Oregon State University
• University of Miami
• University of California Santa Cruz
• Colorado State University
• University of Nebraska Lincoln
• University of California Riverside
• Dartmouth College
• University of Notre Dame
• University of Kentucky
• University of Connecticut
• Case Western Reserve University
• Georgetown University
• University of South Florida
• University of Cincinnati
• University of Missouri Columbia
• University of New Mexico
• Temple University
• University of Oregon
• University of Kansas
• Wayne State University
• Washington State University Pullman
• University of Houston
• M D Anderson Cancer Center University of Texas
• University of Alabama Birmingham
• Indiana University/Purdue University Indianapolis
• University of South Carolina
• Stony Brook University
• University of Oklahoma
• George Mason University
• Drexel University
• Louisiana State University
• Virginia Commonwealth University
• Rensselaer Polytechnic Institute
• University of Colorado Denver
• University of Maryland Baltimore
• Brigham Young University 

TOP UNIVERSITIES IN EUROPE

• University of Cambridge
• University College London
• Eidgenössische Technische Hochschule ETH Zürich / Swiss Federal Institute of Technology Zurich
• University of Edinburgh
• Imperial College London
• University of Manchester
• Catholic University of Leuven
• Utrecht University / Universiteit Utrecht
• École Polytechnique Fédérale de Lausanne
• University of Amsterdam / Universiteit van Amsterdam
• King's College London
• University of Copenhagen / Københavns Universitet
• Ludwig Maximilians Universität München
• University of Helsinki / Helsingin yliopisto
• University of Oslo / Universitetet i Oslo
• Ruprecht Karls Universität Heidelberg
• University of Groningen / Rijksuniversiteit Groningen
• University of Leeds
• Aarhus University / Aarhus Universitet
• Lund University / Lunds Universitet
• Ghent University / Universiteit Gent
• University of Warwick
• Uppsala University / Uppsala Universitet
• University of Glasgow
• Technische Universität München
• Delft University of Technology TU Delft
• Universität Zürich
• VU University of Amsterdam / Vrije Universiteit Amsterdam
• Università di Bologna (Università degli Studi di Bologna)
• Bristol University
• University of Nottingham
• Università degli Studi di Roma La Sapienza
• Universitat de Barcelona
• Universität Wien
• Université de Geneve
• Newcastle University Newcastle upon Tyne
• University of Sheffield
• Universität Hamburg
• Karlsruhe Institute of Technology (Universität Karlsruhe)
• Tel Aviv University
• Karolinska Institute / Karolinska Institutet
• Queen Mary University of London
• Rheinische Friedrich Wilhelms Universität Bonn
• Rheinisch Westfalische Technische Hochschule Aachen
• Universität Bern
• Università degli Studi di Milano
• Royal Institute of Technology / Kungliga Tekniska Högskolan
• Freie Universität Berlin
• Università degli Studi di Padova
• Université de Paris VI / Université Pierre et Marie Curie (comUE Sorbonne Universités)
• University of Exeter
• Wageningen University & Research Centre
• Technical University of Denmark / Danmarks Tekniske Universitet
• Technische Universität Dresden
• Universität Freiburg
• Hebrew University of Jerusalem
• London School of Economics and Political Science
• Eindhoven University of Technology / Technische Universiteit Eindhoven
• University of Gothenburg / Göteborgs Universitet
• University of York
• Humboldt Universität zu Berlin
• Erasmus University of Rotterdam / Erasmus Universiteit Rotterdam
• Universidad Complutense de Madrid
• Stockholm University / Stockholms Universitet
• Charles University in Prague / Univerzita Karlova v Praze
• University of Bergen / Universitetet i Bergen
• Universität Münster
• Universität Tubingen
• University of Twente / Universiteit Twente
• Cardiff University
• Norwegian University of Science & Technology / Norges Teknisk-Naturvitenskapelige Universitet
• Universitat de València
• Universität zu Köln
• Linköping University / Linköpings Universitet
• Technische Universität Berlin
• Trinity College Dublin
• Università di Pisa (Università degli Studi di Pisa)
• University of Leicester
• Radboud University / Radboud Universiteit Nijmegen
• Universidade do Porto
• Universidad de Granada
• Technische Universität Wien
• University of Liverpool
• Università degli Studi di Napoli Federico II
• Aalto University / Aalto-yliopisto
• Lomonosov Moscow State University / Московский государственный университет Ðœ Ð’ Ломоносова
• Johannes Gutenberg Universität Mainz
• Universitat Autònoma de Barcelona
• Politecnico di Milano
• University of Southampton
• Durham University
• Università degli Studi di Firenze
• Università degli Studi di Torino
• Georg-August-Universität Göttingen
• University of Saint Andrews
• Universität Leipzig
• Universidad Autónoma de Madrid
• Universität Basel
• University College Dublin National University of Ireland              

TOP UNIVERSITIES IN MIDDLE – EAST

• King Abdullah University of Science & Technology
• Cairo University
• American University of Beirut
• King Fahd University of Petroleum & Minerals
• United Arab Emirates University
• Qatar University
• Alexandria University
• University of Jordan
• American University in Cairo
• Mansoura University
• Umm Al Qura University
• Ain Shams University
• Masdar Institute of Science & Technology
• Kuwait University
• Jordan University of Science & Technology
• American University of Sharjah
• Assiut University
• Benha University
• Université Saint Joseph de Beyrouth
• Texas A&M University at Qatar
• King Khalid University
• Zagazig University
• Lebanese American University
• Université Cadi Ayyad Marrakech
• An Najah National University
• Khalifa University of Science, Technology and Research
• University of Sharjah
• Birzeit University
• King Faisal University
• University of Tanta
• Hashemite University
• Al Azhar University
• Al Imam Muhammad Ibn Saud Islamic University
• University of Khartoum
• Qassim University
• Université des Sciences et de la Technologie Houari Boumediene
• Yarmouk University
• Kafrelsheikh University
• Université Libanaise
• Alfaisal University
• Najran University
• Sultan Qaboos University
• Taif University
• Helwan University
• Taibah University
• Université Mohammed Premier Oujda
• Zayed University
• Djillali Liabes university of Sidi Bel Abbes
• Islamic University of Gaza
• Fayoum University
• Arab Academy for Science & Technology and Maritime Transport
• Minufiya University
• Université des Frères Mentouri Constantine 1 (Ex Université Mentouri)
• King Saud bin Abdulaziz University for Health Sciences
• Egypt Japan University of Science & Technology
• Al Balqa Applied University
• University of Bahrain
• Jazan University
• Suez Canal University
• Université Abou Bekr Belkaid Tlemcen
• Petroleum Institute Abu Dhabi
• South Valley University
• Université Mohammed V de Rabat
• Tabuk Universtiy
• Université de Bejaia
• Beni Suef University
• British University in Egypt
• Al Quds University Arab University in Jerusalem
• German University in Cairo
• Université Mohamed Khider Biskra
• Université Kasdi Merbah Ouargla
• Higher Colleges of Technology
• Philadelphia University at Jordan
• Université Setif 1 Ferhat Abbas Setif
• University of Babylon
• Al Al-Bayt University
• Université Sidi Mohammed Ben Abdellah Fes
• Université Badji Mokhtar de Annaba
• Université Ibnou Zohr d'Agadir
• École Nationale Polytechnique d'Alger
• Al Akhawayn University Ifrane
• Université de Tunis El Manar
• Gulf University for Science & Technology
• University of Ha'il
• Université Mouloud Mammeri de Tizi Ouzou
• Mutah University
• Université Hassan II de Casablanca
• University of Nizwa
• Abu Dhabi University
• Université des Sciences et de la Technologie d'Oran Mohamed Boudiaf
• Université de Jijel
• Zewail City of Science and Technology
• Université Abdelhamid Ibn Badis Mostaganem
• German Jordanian University
• University of Mosul
• Université de Sfax
• Université M'Hamed Bougara de Boumerdes
• Princess Sumaya University for Technology

TOP UNIVERSITIES IN ASIA

• University of Tokyo
• Peking University
• National Taiwan University
• Kyoto University
• University of Hong Kong
• Seoul National University
• Zhejiang University (National Che Kiang University)
• Shanghai Jiao Tong University
• Nanyang Technological University
• Chinese University of Hong Kong
• Fudan University (Shanghai Medical University)
• Tel Aviv University
• University of Science & Technology of China
• Osaka University
• Korea Advanced Institute of Science & Technology KAIST
• Nanjing University
• Hebrew University of Jerusalem
• Hong Kong University of Science & Technology
• Tohoku University
• City University of Hong Kong
• Wuhan University
• Hong Kong Polytechnic University
• Harbin Institute of Technology
• Huazhong University of Science & Technology
• Sun Yat Sen University (Zhongshan University)
• National Chiao Tung University
• Nagoya University
• Shandong University
• Yonsei University
• National Cheng Kung University
• Technion Israel Institute of Technology
• Xi'An Jiaotong University
• National Tsing Hua University Taiwan
• Korea University
• Kyushu University
• Hokkaido University
• Tongji University
• Weizmann Institute of Science
• Tokyo Institute of Technology
• Sichuan University
• Keio University
• Xiamen University
• Jilin University
• Southeast University
• Beijing Normal University
• University of Tsukuba
• Tianjin University
• Beihang University (Beijing University of Aeronautics and Astronautics)
• Central South University (Zhongnan University
• Nankai University
• Dalian University of Technology
• Lanzhou University
• South China University of Technology
• Soochow University
• Hanyang University
• University of Malaya
• Hiroshima University
• Chongqing University
• King Saud University
• Sungkyunkwan University
• Beijing Institute of Technology
• Ben Gurion University of the Negev
• National Central University
• Kobe University
• Waseda University
• University of Tehran
• Pohang University of Science & Technology
• National Sun Yat Sen University
• University of Electronic Science & Technology of China
• East China Normal University
• China Agricultural University
• Pusan National University (Miryang)
• East China University of Science & Technology
• Hong Kong Baptist University
• Kyungpook (Kyungbook) National University
• Xidian University
• Shanghai University
• King Abdulaziz University
• China University of Geosciences
• Middle East Technical University / Orta DoÄŸu Teknik Üniversitesi
• Bar Ilan University
• National Yang-Ming University
• Indian Institute of Technology Bombay
• University of Science & Technology Beijing
• Northwestern Polytechnical University
• Mahidol University
• Northeastern University China
• Tamkang University
• Beijing University of Chemical Technology
• National Taiwan Normal University
• Tehran University of Medical Sciences
• Istanbul Technical University / Ä°stanbul Teknik Üniversitesi
• Chulalongkorn University
• Universiti Teknologi Malaysia
• Hefei University of Technology
• University of Haifa
• Okayama University